From the 2014 IMWG Conference Series Debate:

56th ASH Annual Meeting
December 8, 2014
San Francisco, CA, USA

Previous Post
Dr. Benedetto Bruno: on post-transplant minimal residual disease monitoring in myeloma (ASH 2014)
Next Post
Dr. Shaji Kumar on long-term myeloma maintenance treatment with ixazomib (ASH 2014)

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.